← brief for 2026-10-18 · People & money
Safety and efficacy of prednisolone, mizoribine and lisinopril combination therapy for severe childhood IgA nephropathy
Key takeaways
This study looked at a combination of three drugs for a rare kidney disease in children. There is no abstract available, so we do not have the study's results.
Who did this work
Yuko Shima (Wakayama Medical University) · Hironobu Mukaiyama (Wakayama Medical University) · Yu Tanaka (Wakayama Medical University) · Wataru Shimabukuro (University of the Ryukyus) · Hiroshi Kaito (Kobe Children's Hospital) · Ryojiro Tanaka (Kobe Children's Hospital) · Kandai Nozu (Kobe University) · Kazumoto Iijima (Kobe University) · Daisuke Tokuhara (Wakayama Medical University) · Norishige Yoshikawa (Takatsuki General Hospital) · Koichi Nakanishi (University of the Ryukyus)
Source
Article · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-10-17
https://doi.org/10.1007/s10157-026-02972-0